Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide
CompletedOBSERVATIONAL
Enrollment
50
Participants
Timeline
Start Date
October 30, 2024
Primary Completion Date
December 30, 2024
Study Completion Date
March 30, 2025
Conditions
Meningioma
Trial Locations (1)
54511
CHRU of NANCY, Vandœuvre-lès-Nancy
All Listed Sponsors
lead
Central Hospital, Nancy, France
OTHER
NCT06255249 - Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide | Biotech Hunter | Biotech Hunter